Streamlining complexity: with 15+ years experience (EU, US and Far East) in Oncology, Rare Diseases and Quality of Life Assessment, Naexture provides ad-interim leadership roles in Clinical Operations and Program Management to end-to-end operationalize clinical research programs.

Swiss Rockets is dedicated to developing groundbreaking medicines that transform the treatment of cancer, infectious diseases, and autoimmune disorders – advancing more effective, equitable, and accessible healthcare for patients worldwide.

CALDRE is a Switzerland based biotech spin-out focussed to revolutionize the way cholestatic-and fibrotic diseases are treated. We develop precise, liver-directed GalNAc-siRNAs to restore bile flow and prevent fibrosis - placing CALDRE in the fast-growing RNA-therapeutics segment of biotech.

RC TRITEC is an established company offering custom synthesis of tritium-labeled compounds, a range of tritiated catalog products, storage service and disposal of radiochemicals. We have over 60 years of experience in the safe handling of tritium gas using in-house developed high-vacuum equipment.

Almac provides the most comprehensive global clinical supply chain solution in the marketplace. Guided by our extensive supply experience, we provide the physical resources and supportive technologies that ensure your clinical supply chain continually delivers across the globe.  

Macrogen Europe GmbH, Swiss branch of Macrogen Europe B.V. (Amsterdam), provides fast, reliable Sanger and NGS sequencing. All sequencing labs are based in Amsterdam. We support research and clinical needs across Europe and Africa with advanced genomic and bioinformatics services.

Mirava Bio is a Swiss BioCommercial Partner enabling emerging biotechs to bring rare disease & gene therapies to Europe, the Middle East & Eurasia. We define optimal go-to-market strategies and execute via a plug-and-play licensed ready platform, minimizing risk while partners retain control.

Topadur Pharma AG, founded in 2015 in Schlieren, is a clinical-stage biopharmaceutical company. Leveraging its proprietary DualTOP™ platform, Topadur develops dual-acting molecules that restore cGMP levels, repairing microcirculation, promoting tissue regeneration, and addressing oxygen deficiency.

Axcura AG is a Swiss based company focusing on the research, development and distribution of high-quality ingredients and raw materials for the chemical, pharmaceutical and life science industry.

Blanc-Labo has been installing and maintaining in Switzerland complex equipments for laboratories for the past 35 years. We have about 4000 customers in Switzerland and France : biotechs, universities, industries . We are based in Lonay near Lausanne.

Swiss Consultant-Network GmbH is developing a new data management system that can be used as a framework for the integration of heterogeneous data in the field of biological research and development. We offer our customers IT engineers, who have in-depth knowledge of computer science disciplines.

Jantar is a clinical R&D company in the field of chronic rhinosinusitis. Its product is a nasal spray of dicholine succinate. Clinical efficacy has been demonstrated by well-documented case studies which showed that the drug relieves all symptoms of the disease. A PCT patent has been filed.

Mabylon is a clinical-stage company leading innovation in human-derived antibody therapeutics for severe allergies, inflammation, and neurological disorders. MY006, our first-in-class multi-specific antibody therapeutic for peanut allergy, is tackling the growing food allergy market.

With 30 years' experience, ICARE stands out as a leader in international standardisation and regulation. We guide healthcare industry through the complex regulatory landscape, ensuring that every healthcare device and product is marketed in full compliance and safety.

GTP Bioways is a French-based CDMO that prioritizes customized services supporting biopharmaceutical companies throughout their journey from R&D to clinics. With more than 20 years’ experience, we specialize in process development and GMP manufacturing of biologics, bioconjugates and nanodrugs.

Enantios is a Swiss startup revolutionizing molecular characterization with in-solution structural analysis of chiral complex molecules and Antibody drug Conjugates (ADCs). Enantios delivers solutions for quality control and drug development in pharmaceutical, biotech, and chemical industries.

As a health company, we envision empowering global well-being by pioneering biological solutions drawn from nature. Our mission: Unlock the full potential of exDNA across diverse indications. Our AND Technology Platform has the primary focus on controlling disease caused by pathogenic bacteria.

Our platform enables efficient, tunable multiplex gene silencing, modulating multiple targets in one construct for superior safety and potency over traditional editing. Its modular design suits various cell and gene engineering applications.

We are specialists for laboratory consumables and pipette service – with a focus on liquid handling. We combine our expertise with a consultative approach so that we can fully understand the daily work of scientists and researchers in order to provide any support needed.

Accelerate your development with CMC & More  *   In today's fast pace environment, optimizing your CMC (Chemistry, Manufacturing & Controls) package is crucial for cost-effective and timely product development. CMC & More is specialized in providing tailored advisory services that cater your ne

Innovalex is a Switzerland-based company specializing in legal solutions for innovative businesses in the life sciences sector. It offers services ranging from business formation to growth support, as well as legal consultancy in various legal fields.

Ultimate Medicine is a Swiss preclinical biotech focused on preserving independence and quality of life for patients with Alzheimer's disease and other dementias.

EVIIVE develops single extracellular vesicle-based diagnostics to predict immunotherapy response and monitor tumor microenvironment in real time. Our platform integrates advanced flow analytics and machine learning for precision oncology applications.

TheraPPI Bioscience, a preclinical biotechnology company developing small molecules modifying protein interactions in oncology, rare diseases and inflammation

The Future Rewritten: Unlocking Genome Editing. By fusing directed evolution, high-throughput characterization, and AI, Nerai creates novel CRISPR editors, more precise and more powerful, making gene editing safer and accessible to more patients.

AVEctivate supports pharma, biotech and diagnostic companies aiming to make a positive difference to patients, and health care providers by offering strategic consulting, project management and interim management. Believing that change is the only constant, we embrace the future as an opportunity.

We want to be strategic collaborator with executive management and empower in-house IR/PR professionals to help you build lasting and mutually beneficial relationships with investors, partners, media, and other stakeholders.

Baker McKenzie is an international law firm with offices in Geneva and Zurich, offering top-tier legal advice across all areas of business law. Our team of 130 lawyers provides domestic and international clients with innovative solutions across 74 offices in 45 countries.

Tridek-One is a biotech start-up developing first-in-class CD31 agonist modalities designed to restore the immune balance.

Life Science Cares Switzerland uses the innovation, financial and human resources of the life science industry to support local charitable projects. Main focus is promoting educational equity by providing young people from socially disadvantaged backgrounds with opportunities in our industry.

Beech Biotech is developing a novel treatment for preeclampsia, an severe unmet medical need that takes the lives of 70,000 women and 500,000 babies each year. The company is developing a novel placenta-impermeable antibody and works with a network of expert industry consultants and contractors.

XEMPERIA, a spin-off from the University of Fribourg, is pioneering a groundbreaking approach to blood testing that leverages the body's immune response to detect breast cancer at its earliest and most treatable stage.

Umlaut.bio develops first-in-biology small molecules focusing on tRNAs that protect signalling transduction mRNAs from degradation. Addressing this previously undrugged fundamental biochemical principle  could be able to selectively prevent the growth of cancer as well as  proinflammatory cells.

Jeffries IP stands out for delivering bespoke IP solutions tailored to each client's unique needs. Our industry knowledge, legal expertise and understanding of commercial realities allow us to provide practical strategic advice to help clients unlock the value of their intellectual property.

Parithera is pioneering an AI-ready, clinical-grade liquid biopsy platform for single-cell analysis. Our platform is ideally positioned to study cancer treatment resistance.

MicThera harnesses microbes to discover breakthrough therapeutics, leveraging microbial bioactive molecules -synthetically produced- to overcome therapy resistance. Our discovery platform unlocks microbial-inspired therapeutics to develop innovative treatments.

SPILLO stands out for its ability to identify target and off-target proteins for any molecule—whether in development or on the market—on a proteome-wide scale, offering strategic advantages across all stages of drug R&D. Powered by exclusive, experimentally validated physics-based technology.

Axxam is an innovative research and discovery organization providing services for the identification and validation of bioactive molecules across the life sciences industry and supporting pharmaceutical and biotech companies from target validation to hit and lead identification.

The grow Foundation provides small and large Life Sciences companies ready-to-use laboratories, offices, piloting and production facilities in Wädenswil/Horgen, in size ranging from a few working benches to several thousand m2.

Devintec Pharma is focused on B2B partnerships through out-licensing innovative substance-based medical devices. We apply DevinPro™ technology, that addresses root causes and creates a protective barrier for lasting relief, to our patended products in gastroenterology, dermatology, and gynecology.

Cure Pharma specializes in clinical supply management, including global supply chain coordination, comparator sourcing, logistics, and innovative labelling solutions. With a strong network and regulatory expertise, we ensure efficient, compliant, and reliable supply solutions for clinical studies.

Wemedoo AG is a clinical information specialist who specializes in the development of clinical data information systems, as well as data collection, management, analysis, and reporting. We transform healthcare by seamlessly unifying clinical research and clinical practice.

A swiss-based company developing therapeutics for chronic inflammation. We are engineering novel bi-functional Duokine therapeutics, rationally designed to simultaneously target distinct immune cell populations and disease-relevant pathways.

Basel Biotech Consutling GmbH provides biotechs and mid-stage pharmas with support on financing and business development. The expertise is based on over 20 years experience in investments having worked as a pharma analyst, fund manager, investor relations and business development professional.

Nxera Pharma is a tech-driven biopharma company focused on specialty medicines for unmet needs in Japan and globally. With 30+ active programs in neurology, GI, immunology, metabolic, and rare diseases, Nxera employs 350+ people across Japan, the UK, Switzerland, and South Korea.

Livinovea is a full-service provider and consultancy for life sciences, specializing in business, operational, and technical excellence. We help companies unlock their potential, identify untapped opportunities, and solve complex challenges, to achieve growth and measurable results.

Quotient Sciences is a drug development and manufacturing accelerator providing integrated programs and tailored services across the entire development pathway. Cutting through silos across a range of drug development capabilities, we save precious time and money in getting drugs to patients.

Provides consulting services to pharma and biotech clients in market access and pricing area. Support geographic expansion strategies for Asian life sciences companies. Trading in nutraceuticals products for European markets.

The Bloc Switzerland is a creative, full-service agency with 30 years of experience in impactful health communication. Our medical and creative teams craft corporate identities, websites, social media campaigns, brand brochures, and mode of action and corporate videos.

TransHeps specializes in iDILI causality assessments, supporting drug developers in clinical trials and managing drug-induced liver injuries. Leveraging cutting-edge expertise, we provide reliable solutions to improve drug safety and accelerate pharmaceutical innovations.

Our single-use bioreactor simplifies and accelerates cell culture with automation and closed systems, accommodating volumes from 30 mL up to 30 L in the same vessel. Designed for a broad range of cells and for the entire product lifecycle (clinical research, process development, manufacturing).

Genevant brings world-class delivery platforms that include best-in-class lipid nanoparticle (LNP) technology and next generation ligand conjugate technology, the industry’s most robust and expansive LNP patent estate, decades of experience and expertise in nucleic acid drug development.

WittKieffer is a top 10 executive search and leadership advisory firm exclusively specialised in life sciences organizations operating at the intersection of academia, science, and healthcare.

metaLead is an early-stage life science spinout from the University of Zurich, supported by reputable investors, i.e., BaseLaunch. We aim to revolutionize the treatment landscape for metal-related diseases, starting with Wilson disease, leveraging our platform of novel, rationally designed peptides.

Leman Biotech is a clinical-stage biotech company. We are a spin-off of EPFL, dedicated to develop next-generation metabolic cancer immunotherapies. Our exclusive metabolic reprogramming technology reverses T-cell exhaustion, a major bottleneck in cancer immunotherapies.

dEEGtal develops AI-driven solutions to enhance EEG analysis, starting with a medical device for epilepsy diagnosis. While focused on clinical applications, we are expanding to offer AI models that provide deeper insights into EEG data for neuroscience, pharma, and industry partners.

Partner with INNOSIAMO to accelerate innovation and global success. We empower our clients getting them investor-ready and set up for strategic partnerships through tailored advisory and global connections. INNOSIAMO combines deep industry expertise with a boutique approach.

Pharmabotix leads the way in robot-based automation solutions for the pharma & biotech industry, offering a seamless journey from concept to turnkey implementation. Our products and solutions are distinguished by their cutting-edge innovation, user-friendly simplicity, and space-efficient design.

Neurosterix is a biopharmaceutical company focused on developing allosteric modulators for the treatment of neurological disorders. Our drug discovery and development platform identifies and develops allosteric modulators.

Abbmira therapeutics is a Basel based biotech founded by experience scientists and entrepreneurs in September 2024. Abbmira develops first-in-class small molecules to fine-tune native immunity to treat difficult-to-treat cancers and chronic diseases.

OptoLumina is dedicated to advancing research and promoting the use of optogenetics through cutting-edge illumination technologies. Our flagship product, the Lumiplate, is evidence of our commitment to innovation and quality.

We "think data" and "speak biology", partnering with our clients to transform lives. Our team combines deep biological knowledge with proven expertise in AI & bioinformatics to tackle complex data challenges. Via our AI-native Bio|Verse platform, we accelerate biomarker discovery & drug development.

ObelysQ is a leading consulting firm offering tailored solutions to the pharma industry aiming at enhancing compliance and improving processes in the execution of clinical trials. Our Headquarters are in Neuchâtel, with a branch in Poland.

Clinigen is a global, specialist pharmaceutical services company focused on providing ethical access to medicines. We support pharma and biotech companies across the product lifecycle, from clinical through to commercial and operate from sites in North America, Europe, Africa and Asia Pacific.

At CxO, we drive biotech startups toward growth by optimizing resource management and operational efficiency. As partners, we empower firms to innovate and scale. Our veteran team offers strategic insights to accelerate timelines, optimize ROI, and enhance workflows, ensuring client success

InVirtuoLabs is pioneering the next-generation laboratory by integrating AI with molecular simulations to revolutionize drug discovery. Our platform generates up to 1 billion novel molecules per day, rapidly screening and identifying the most promising ligands for specific biological targets.

Avenza Consulting has been created to support pharma, biotech companies, startups to develop and grow by offering Strategic Consulting, R&D services to foster innovation, Program & Portfolio Management to optimize projects, and Operational Excellence to streamline processes.

Signal26 Biotherapeutics is a biotechnology startup dedicated to advancing a novel antibody for treating psoriasis. In collaboration with interdisciplinary experts, we lead research into interleukin 26 (IL-26) and its role in the signalling pathways involved in autoimmune disorders.

Precise Health develops AI-powered platforms for bacteriophage discovery, host-matching, and engineering. We serve hospitals, biotech, and pharma in the $50B+ anti-infectives and diagnostics markets, addressing the urgent global threat of antimicrobial resistance

Juvion develops advanced therapeutics aimed at preserving neuron-muscle connectivity, tackling immobility and sarcopenia to extend healthspan.

We provide a portfolio of models for efficacy pharmacology in autoimmunity, immuno-oncology, and transplantation. Our humanized mouse and tumor xenograft platforms enable translational evaluation of biologics, cell therapies, and innovative immunotherapies.

Release Therapeutics is a preclinical-stage BioMedTech company developing the first cell macroencapsulation technology specifically designed to get therapeutic proteins where they are needed most, in the CNS and beyond.

Enzene is a fully integrated CIDMO with sites in Pune (India) & New Jersey (USA), offering discovery to commercial supply. Its EnzeneX™ FCCM™ tech leads next-gen biologics, aiming to cut mAb costs below $40/g by 2025. Learn more at www.enzene.com.

BeOne Medicines is a global oncology company developing innovative, affordable, and accessible cancer treatments worldwide. We expedite development of our diverse pipeline of novel therapeutics through strong internal capabilities and collaborations. Our 11,000 colleagues span six continents.

Justin Stindt Consultants is a consulting firm specializing in Strategy & Market Access advisory services for the pharmaceutical, biotech and medical device industries.

The Nikon Microscope Solutions unit is focused on serving customers in research, biotech/pharma, the clinical laboratory, and academia with industry leading microscope-based imaging solutions. In addtion the Nikon BioImaging Lab, is a CRO that provides microscope-based imaging and analysis services.

We are offering worldwide professional medical writing and related services to the pharmaceutical (human & veterinary), biotech, medical device and other industries, CROs and academic institutions. With over 20 years of experience in the field, we guarantee the best possible medical writing.

Skyvor Medical develops AI-powered digital platforms (RecruitNavigator, ATOM EDC) to  accelerate the feasibility (protocol, site optimizations) and the data collection in clinical trials. Together with our data management services, we offer a turnkey solution for managing clinical trial data.

Founded in mid-2022, T-Oncology is a Swiss biotech startup dedicated to transforming cancer treatment through innovative therapies. Our Mission: Give hope to patients by creating advanced therapeutics that offer safe and more effective treatment options, affordable for patients worldwide.

Amporin Pharmaceuticals AG is developing a new class of small molecule amyloid pore inhibitors as the first potential acute oral disease-modifying treatments for degenerative diseases. Our vision is to cure 6 major degenerative diseases with a simple pill, starting with Parkinson’s disease and ALS.

Procavea Biotech is an ETH Spin-off company developing an innovative protein-based RNA delivery platform. Our focus is to generate siRNA therapeutics in extrahepatic disease areas that are currently unreachable.

Prasfarma is a Pharmaceutical Company that operates as a CMO and CDMO) with experience in cytostatics, high potency products and biologics. Our flexibility & state of the art technologies, make us the ideal partner for small productions or R&D projects (pilot plant) and commercial supply (factory).

Access2Health partners with biotechs, providing flexible, cost-effective support to maximise asset value. We offer strategic guidance in market potential, evidence generation, pricing, and value strategy, helping biotech leaders make informed decisions that strengthen their position with investors.

ICE Biopharma in-licenses, registers and commercialises specialty and rare disease drugs in Europe and Canada, to ensure that European and Canadian patients have access to the breakthrough therapies they deserve.

ANSEA is a global consulting firm enabling pharmaceuticals, biopharmaceuticals and medical device companies navigate through the complexities of healthcare systems across the world and helping bring their solutions to patients.

GANDA offers tailored G&A services to Life Sciences companies, providing fractional expertise in financial management and planning, human capital, and corporate finance, among others. Their deep industry experience ensures seamless integration without lengthy onboarding.

Xcube.bio invests capital, knowledge and capabilities in the European market entry of late-stage biopharmas, with the objective to create partners' own commercial footprint and revenue streams. We offer a unique value proposition that open and de-risk the European market for innovative therapies.

Chelonia collaborates with industry, academia, and public institutions to accelerate R&D, commercialize innovations, and secure funding. We offer strategic partnerships, expert guidance, and project support to maximize impact.

Allegria Therapeutics was founded in Basel in 2023. Pursuing a differentiated portfolio of proprietary therapeutic approaches around biological targets that selectively modulate mast cells, Allegria plans to redefine the treatment landscape for allergy and mast cell-mediated inflammatory diseases.

Complyomics supports Life Sciences companies in 3 main areas: Build and maintain robust Quality Systems in compliance with regulatory requirements. Provide externalized QA. Develop expertise in Bioanalytical and Analytical areas. Identify / assess sub-contractors; supervise outsourced activities.

Tandem Therapeutics (Spin-off ETH Zurich & PSI) is tackling the growing unmet medical need in treating fibrosis with precision extracellular matrix targeting. Our novel peptide drug conjugates selectively target mechanical changes in the fibrotic extracellular matrix to potentially halt progression.

ENABLE Biotech aims to partner with companies from research to clinical stage to address specific challenges of manufacturing Advanced Therapies. Our next generation CDMO model enables an attractive pricing structure and expertise in CMC for speed to Phase I/IIa.

ARTBIO is a clinical-stage radiopharmaceutical company focused on developing a new class of alpha radioligand therapies (ARTs) to transform cancer treatment. ARTBIO's approach centers on utilizing the alpha-emitting isotope Pb212 to target cancer cells while minimizing damage to healthy tissues.

NanThermix SA is a pioneer in nanoscale temperature control within living cells for applications across life sciences, from academic research to biomedical fields, based on a novel technollogy of all-optical nanodiamond heater - thermometer.

HekeTiss, a UNIGE/HUG spin-off, enhances lives by pioneering cell-therapy treatments for ulcerative skin conditions. Innovating for a healthier tomorrow.

ORACTIVE develops medications against modern lifestyle diseases for global markets, based on our innovative, versatile ORASMART platform technology and proven APIs. Tolerability, convenience and medication comfort are our core elements for patient adherence and ultimate success of oral therapies.